|
US20070122904A1
(en)
*
|
2000-09-29 |
2007-05-31 |
Unisearch Limited |
Method and apparatus for culturing cells
|
|
US20030175688A1
(en)
*
|
2002-03-15 |
2003-09-18 |
Rukmini Pennathur-Das |
Method for the purification and production of oncolytic adenoviruses
|
|
US20050009168A1
(en)
*
|
2003-05-12 |
2005-01-13 |
Robbins Joan Marie |
Methods and apparatus for Adeno associated virus purification
|
|
DE602004030327D1
(en)
|
2003-05-21 |
2011-01-13 |
Genzyme Corp |
METHOD FOR PRODUCING PREPARATIONS OF RECOMBINANT AAV VIRIONS LARGELY FREE FROM EMPTY CAPSIDES
|
|
US20040248826A1
(en)
*
|
2003-06-03 |
2004-12-09 |
Alberto Auricchio |
Treatment of cancer by in vivo gene-transfer induced TIMP-3 expression
|
|
US7261882B2
(en)
|
2003-06-23 |
2007-08-28 |
Reagents Of The University Of Colorado |
Methods for treating neuropathic pain by administering IL-10 polypeptides
|
|
MX360727B
(en)
|
2004-06-01 |
2018-11-14 |
Genzyme Corp |
Compositions and methods to prevent aav vector aggregation.
|
|
AU2005322353B2
(en)
|
2004-12-23 |
2011-09-01 |
Medimmune, Llc |
Non-tumorigenic MDCK cell line for propagating viruses
|
|
KR100823157B1
(en)
*
|
2004-12-30 |
2008-04-21 |
재단법인 목암생명공학연구소 |
How to mass produce recombinant adeno-associated viruses
|
|
US9198984B2
(en)
|
2006-04-28 |
2015-12-01 |
The Trustees Of The University Of Pennsylvania |
Scalable production method for AAV
|
|
CA2663522C
(en)
|
2006-09-15 |
2015-06-02 |
Medimmune, Llc |
Mdck cell lines supporting viral growth to high titers and bioreactor process using the same
|
|
EP2031048B2
(en)
|
2007-08-31 |
2019-05-01 |
The Procter and Gamble Company |
Liquid acidic hard surface cleaning composition
|
|
EP2039747A1
(en)
|
2007-09-17 |
2009-03-25 |
The Procter and Gamble Company |
Process for treating hard surface
|
|
EP2039748A1
(en)
|
2007-09-17 |
2009-03-25 |
The Procter and Gamble Company |
Process of treating inclined hard surface
|
|
CN102216450B
(en)
|
2008-09-24 |
2014-05-14 |
米迪缪尼有限公司 |
Methods of Culturing Cells, Propagating and Purifying Viruses
|
|
HUE057606T2
(en)
|
2009-05-02 |
2022-05-28 |
Genzyme Corp |
Gene therapy for neurodegenerative disorders
|
|
IN2012DN06629A
(en)
*
|
2010-01-28 |
2015-10-23 |
Philadelphia Children Hospital |
|
|
WO2011097447A2
(en)
*
|
2010-02-04 |
2011-08-11 |
Neurologix, Inc. |
Production of recombinant virus
|
|
WO2012048275A2
(en)
|
2010-10-08 |
2012-04-12 |
Caridianbct, Inc. |
Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
|
|
EP3219313B1
(en)
|
2011-04-18 |
2020-10-28 |
National Center of Neurology and Psychiatry |
Drug delivery particle and method for producing the same
|
|
US20140107321A1
(en)
*
|
2011-05-26 |
2014-04-17 |
Dr. Reddy's Laboratories Limited |
Purification of antibodies
|
|
SI2744895T1
(en)
*
|
2011-09-08 |
2016-03-31 |
Uniqure Ip B.V. |
Removal of contaminating viruses from aav preparations
|
|
HUE037482T2
(en)
|
2013-01-08 |
2018-08-28 |
Genzyme Corp |
Use of Inos inhibitors to increase virus yield in culture
|
|
US11332719B2
(en)
|
2013-03-15 |
2022-05-17 |
The Broad Institute, Inc. |
Recombinant virus and preparations thereof
|
|
SG11201508297YA
(en)
|
2013-04-17 |
2015-11-27 |
Genzyme Corp |
Compositions and methods for treating and preventing macular degeneration
|
|
KR102069561B1
(en)
|
2013-07-11 |
2020-01-23 |
다카라 바이오 가부시키가이샤 |
Method for manufacturing non-enveloped virus
|
|
KR102234695B1
(en)
|
2014-02-06 |
2021-04-02 |
젠자임 코포레이션 |
Compositions and methods for treating and preventing macular degeneration
|
|
WO2015191508A1
(en)
|
2014-06-09 |
2015-12-17 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
|
US10023846B2
(en)
|
2014-07-10 |
2018-07-17 |
Takara Bio Inc. |
Production method for non-enveloped virus particles
|
|
WO2016049421A1
(en)
|
2014-09-26 |
2016-03-31 |
Terumo Bct, Inc. |
Scheduled feed
|
|
MX2017005834A
(en)
|
2014-11-05 |
2017-11-17 |
Voyager Therapeutics Inc |
Aadc polynucleotides for the treatment of parkinson's disease.
|
|
SG10202001102XA
(en)
|
2014-11-14 |
2020-03-30 |
Voyager Therapeutics Inc |
Modulatory polynucleotides
|
|
SG11201703281RA
(en)
|
2014-11-14 |
2017-05-30 |
Voyager Therapeutics Inc |
Compositions and methods of treating amyotrophic lateral sclerosis (als)
|
|
EP3230441A4
(en)
|
2014-12-12 |
2018-10-03 |
Voyager Therapeutics, Inc. |
Compositions and methods for the production of scaav
|
|
EP3243904A4
(en)
|
2015-01-09 |
2018-06-27 |
Takara Bio Inc. |
Method for producing non-enveloped viral particles
|
|
CN107428799A
(en)
|
2015-01-13 |
2017-12-01 |
阿尔法韦士曼公司 |
Purify adeno-associated virus (AAV) and/or the method and its gradient and flow type buffer solution of recombinant adeno-associated virus (rAAV)
|
|
EP3054006A1
(en)
|
2015-02-09 |
2016-08-10 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Recombinant adeno-associated virus particle purification with multiple-step anion exchange chromatography
|
|
EP3054007A1
(en)
*
|
2015-02-09 |
2016-08-10 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step
|
|
EP3368054A4
(en)
|
2015-10-28 |
2019-07-03 |
Voyager Therapeutics, Inc. |
REGULATORY EXPRESSION USING AN ADENO-ASSOCIATED VIRUS (AAV)
|
|
PH12018501168B1
(en)
*
|
2015-12-01 |
2024-05-17 |
Spark Therapeutics Inc |
Scalable methods for producing recombinant adeno-associated viral (aav) vector in serum-free suspension cell culture system suitable for clinical use
|
|
WO2017160360A2
(en)
|
2015-12-11 |
2017-09-21 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aav9
|
|
EP3992283A1
(en)
|
2015-12-11 |
2022-05-04 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aavrh10
|
|
WO2017100674A1
(en)
|
2015-12-11 |
2017-06-15 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aav1
|
|
EP3387117B1
(en)
|
2015-12-11 |
2022-11-23 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aav8
|
|
WO2017112948A1
(en)
*
|
2015-12-24 |
2017-06-29 |
University Of Florida Research Foundation, Inc. |
Improved aav production using suspension adapted cells
|
|
JP7364306B2
(en)
|
2016-03-31 |
2023-10-18 |
スパーク セラピューティクス インコーポレイテッド |
Column-based highly scalable rAAV manufacturing process
|
|
EP3448874A4
(en)
|
2016-04-29 |
2020-04-22 |
Voyager Therapeutics, Inc. |
Compositions for the treatment of disease
|
|
EP3448987A4
(en)
|
2016-04-29 |
2020-05-27 |
Voyager Therapeutics, Inc. |
Compositions for the treatment of disease
|
|
WO2017201258A1
(en)
|
2016-05-18 |
2017-11-23 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating huntington's disease
|
|
JP7066635B2
(en)
|
2016-05-18 |
2022-05-13 |
ボイジャー セラピューティクス インコーポレイテッド |
Modulatory polynucleotide
|
|
CN109415696A
(en)
|
2016-05-25 |
2019-03-01 |
泰尔茂比司特公司 |
Cell amplification
|
|
EP4219724A3
(en)
|
2016-08-23 |
2023-09-27 |
Akouos, Inc. |
Compositions and methods for treating non-age-associated hearing impairment in a human subject
|
|
US11298041B2
(en)
|
2016-08-30 |
2022-04-12 |
The Regents Of The University Of California |
Methods for biomedical targeting and delivery and devices and systems for practicing the same
|
|
CN110325203A
(en)
|
2017-01-07 |
2019-10-11 |
西莱克塔生物科技公司 |
Medelling with the immunosuppressor of synthesis nano-carrier coupling is administered
|
|
CN110612344B
(en)
|
2017-03-31 |
2023-09-12 |
泰尔茂比司特公司 |
cell expansion
|
|
US11624046B2
(en)
|
2017-03-31 |
2023-04-11 |
Terumo Bct, Inc. |
Cell expansion
|
|
CA3061652A1
(en)
|
2017-05-05 |
2018-11-08 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating amyotrophic lateral sclerosis (als)
|
|
AU2018261003A1
(en)
|
2017-05-05 |
2019-11-14 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating Huntington's Disease
|
|
CA3066358A1
(en)
|
2017-06-07 |
2018-12-13 |
Spark Therapeutics, Inc. |
Enhancing agents for improved cell transfection and/or raav vector production
|
|
JOP20190269A1
(en)
|
2017-06-15 |
2019-11-20 |
Voyager Therapeutics Inc |
Aadc polynucleotides for the treatment of parkinson's disease
|
|
PE20200737A1
(en)
*
|
2017-06-30 |
2020-07-23 |
Spark Therapeutics Inc |
AAV VECTOR COLUMN PURIFICATION METHODS
|
|
US11497576B2
(en)
|
2017-07-17 |
2022-11-15 |
Voyager Therapeutics, Inc. |
Trajectory array guide system
|
|
US11512327B2
(en)
|
2017-08-03 |
2022-11-29 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of AAV
|
|
AU2018338728B2
(en)
|
2017-09-29 |
2025-01-02 |
Centre National De La Recherche Scientifique (Cnrs) |
Rescue of central and peripheral neurological phenotype of Friedreich's Ataxia by intravenous delivery
|
|
WO2019079242A1
(en)
|
2017-10-16 |
2019-04-25 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis (als)
|
|
TW202413649A
(en)
|
2017-10-16 |
2024-04-01 |
美商航海家醫療公司 |
Treatment of amyotrophic lateral sclerosis (als)
|
|
SG11202006232SA
(en)
*
|
2017-12-29 |
2020-07-29 |
Baxalta Inc |
Adeno-associated virus purification methods
|
|
EP3762500A1
(en)
|
2018-03-06 |
2021-01-13 |
Voyager Therapeutics, Inc. |
Insect cell manufactured partial self-complementary aav genomes
|
|
US12319929B2
(en)
|
2018-05-15 |
2025-06-03 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of Parkinson's disease
|
|
US20210207167A1
(en)
|
2018-05-16 |
2021-07-08 |
Voyager Therapeutics, Inc. |
Aav serotypes for brain specific payload delivery
|
|
EP3793615A2
(en)
|
2018-05-16 |
2021-03-24 |
Voyager Therapeutics, Inc. |
Directed evolution of aav to improve tropism for cns
|
|
AU2019285186B2
(en)
|
2018-06-14 |
2025-05-29 |
Regenxbio Inc. |
Anion exchange chromatography for recombinant AAV production
|
|
CN112567035A
(en)
|
2018-07-02 |
2021-03-26 |
沃雅戈治疗公司 |
Treatment of amyotrophic lateral sclerosis and spinal cord related disorders
|
|
EP3826719A1
(en)
|
2018-07-24 |
2021-06-02 |
Voyager Therapeutics, Inc. |
Systems and methods for producing gene therapy formulations
|
|
CN109182281B
(en)
*
|
2018-08-31 |
2022-08-02 |
首都医科大学 |
Method and kit for treating adeno-associated virus
|
|
CN121160803A
(en)
|
2018-09-28 |
2025-12-19 |
沃雅戈治疗公司 |
Ataxin expression constructs with engineered promoters and methods of use thereof
|
|
US20210348242A1
(en)
|
2018-10-04 |
2021-11-11 |
Voyager Therapeutics, Inc. |
Methods for measuring the titer and potency of viral vector particles
|
|
US20220064671A1
(en)
|
2019-01-18 |
2022-03-03 |
Voyager Therapeutics, Inc. |
Methods and systems for producing aav particles
|
|
CA3138525A1
(en)
|
2019-04-28 |
2020-11-05 |
Selecta Biosciences, Inc. |
Methods for treatment of subjects with preexisting immunity to viral transfer vectors
|
|
WO2020223274A1
(en)
|
2019-04-29 |
2020-11-05 |
Voyager Therapeutics, Inc. |
SYSTEMS AND METHODS FOR PRODUCING BACULOVIRAL INFECTED INSECT CELLS (BIICs) IN BIOREACTORS
|
|
JP7539420B2
(en)
*
|
2019-06-28 |
2024-08-23 |
武田薬品工業株式会社 |
Methods for purifying adeno-associated viruses
|
|
EP4010465A1
(en)
|
2019-08-09 |
2022-06-15 |
Voyager Therapeutics, Inc. |
Cell culture medium for use in producing gene therapy products in bioreactors
|
|
TW202122582A
(en)
|
2019-08-26 |
2021-06-16 |
美商航海家醫療公司 |
Controlled expression of viral proteins
|
|
WO2021124152A1
(en)
|
2019-12-19 |
2021-06-24 |
Pfizer Inc. |
Compositions and methods for nucleic acid transfection using cationic polymers and stabilizers
|
|
MX2022010050A
(en)
|
2020-02-21 |
2022-09-05 |
Akouos Inc |
Compositions and methods for treating non-age-associated hearing impairment in a human subject.
|
|
EP3919613B1
(en)
*
|
2020-06-05 |
2024-08-07 |
Sartorius BIA Separations d.o.o. |
Enhanced purification of adeno-associated virus to more effectively remove contaminating dna
|
|
US20230295656A1
(en)
|
2020-08-06 |
2023-09-21 |
Voyager Therapeutics, Inc. |
Cell culture medium for use in producing gene therapy products in bioreactors
|
|
WO2022043926A1
(en)
*
|
2020-08-31 |
2022-03-03 |
Intas Pharmaceuticals Ltd. |
Process for preparation of recombinant adeno-associated virus particle
|
|
EP4217087A2
(en)
*
|
2020-09-23 |
2023-08-02 |
Codiak BioSciences, Inc. |
Process for preparing extracellular vesicles
|
|
AR123776A1
(en)
|
2020-10-15 |
2023-01-11 |
Hoffmann La Roche |
NUCLEIC ACID CONSTRUCTS FOR THE SIMULTANEOUS ACTIVATION OF GENES
|
|
CA3197730A1
(en)
|
2020-10-15 |
2022-04-21 |
F. Hoffman-La Roche Ag |
Nucleic acid constructs for va rna transcription
|
|
JP7683230B2
(en)
*
|
2021-01-27 |
2025-05-27 |
東ソー株式会社 |
Methods for purifying adeno-associated viruses
|
|
WO2022187548A1
(en)
|
2021-03-03 |
2022-09-09 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
US20240141377A1
(en)
|
2021-03-03 |
2024-05-02 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
WO2023198685A1
(en)
|
2022-04-13 |
2023-10-19 |
F. Hoffmann-La Roche Ag |
Method for determining aav genomes
|
|
GB202205514D0
(en)
*
|
2022-04-13 |
2022-05-25 |
Freeline Therapeutics Ltd |
Mechanical lysis
|
|
JP2025517987A
(en)
|
2022-05-23 |
2025-06-12 |
エフ． ホフマン－ラ ロシュ アーゲー |
Raman-Based Methods for Identification of AAV Particle Serotypes and AAV Particle Loading Status
|
|
CA3258165A1
(en)
|
2022-06-03 |
2023-12-07 |
F. Hoffmann-La Roche Ag |
Method for producing recombinant aav particles
|
|
AR129895A1
(en)
|
2022-07-14 |
2024-10-09 |
Hoffmann La Roche |
METHOD FOR PRODUCING RECOMBINANT AAV PARTICLES
|
|
WO2024054983A1
(en)
|
2022-09-08 |
2024-03-14 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
IL318766A
(en)
|
2022-09-12 |
2025-04-01 |
Hoffmann La Roche |
Method for separating full and empty aav particles
|
|
IL322001A
(en)
|
2023-02-07 |
2025-09-01 |
Hoffmann La Roche |
Method for the detection of anti-aav particle antibodies
|
|
EP4683676A1
(en)
|
2023-03-21 |
2026-01-28 |
F. Hoffmann-La Roche AG |
Method for the production of recombinant aav particle preparations
|
|
WO2024206396A1
(en)
*
|
2023-03-28 |
2024-10-03 |
Biogen Ma Inc. |
Methods of recombinant adeno-associated virus (raav) production
|
|
CN120981561A
(en)
|
2023-04-03 |
2025-11-18 |
建新公司 |
Cell lysis device and its usage
|
|
WO2024233791A1
(en)
|
2023-05-11 |
2024-11-14 |
Seelos Therapeutics, Inc. |
Methods of treating neurodegenerative disorders
|
|
WO2025168663A1
(en)
|
2024-02-09 |
2025-08-14 |
F. Hoffmann-La Roche Ag |
Method for producing recombinant adeno-associated viral particles
|
|
WO2025252480A1
(en)
|
2024-06-07 |
2025-12-11 |
F. Hoffmann-La Roche Ag |
Method for purifying plasmid dna
|
|
CN119639868B
(en)
*
|
2025-02-20 |
2025-09-23 |
南京鸿明生物科技有限公司 |
Gene extraction method for AAV third-generation sequencing
|